US1.5

AstraZeneca to build US.5 billion manufacturing plant in Singapore
AstraZeneca to build US$1.5 billion manufacturing plant in Singapore
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that enable precision therapy for cancer.
AstraZeneca to build US.5 billion manufacturing plant in Singapore
AstraZeneca to build US$1.5 billion manufacturing plant in Singapore
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that enable precision therapy for cancer.
Singapore-based Princeton Digital gets green loan for US.5 billion Asia AI hub
Singapore-based Princeton Digital gets green loan for US$1.5 billion Asia AI hub
PRINCETON Digital Group secured a US$280 million green loan to help finance a US$1.5 billion data centre it’s building in southern Malaysia, a first for the Asian infrastructure operator...
Blackstone makes rival US.5 billion bid for troubled Hipgnosis
Blackstone makes rival US$1.5 billion bid for troubled Hipgnosis
US asset manager Blackstone has made a US$1.5 billion takeover bid for UK music rights owner Hipgnosis Songs Fund, beating out rival Concord’s offer.The bid, issued by Blackstone Europe...
Microsoft invests US.5 billion in UAE’s G42, will get board seat
Microsoft invests US$1.5 billion in UAE’s G42, will get board seat
MICROSOFT will invest US$1.5 billion in the United Arab Emirates’ top artificial intelligence (AI) firm, G42, bolstering the Abu Dhabi-based company’s commitment to scale back its presence in China.As...